Literature DB >> 6863076

Ependymomas of the spinal cord.

R E Peschel, D S Kapp, F Cardinale, E E Manuelidis.   

Abstract

Many patients with spinal cord ependymomas (SCE) undoubtedly benefit from post-operative radiation therapy; however, because of the wide variability in the total doses given, the optimal post-operative dose for SCE remains unclear. Several recent papers recommend total doses of 4000 rad to 5000 rad in 4 1/2 to 6 weeks. Unfortunately, only a small number of patients reported in the literature have been consistently treated to these high dose recommendations. Nine consecutive adult patients with SCE have been treated in a consistent way at Yale-New Haven Hospital with total doses of approximately 4500 rad to 5000 rad at 180 rad to 200 rad per day. The acute and chronic morbidity from such treatment has been minimal and no patient has had a local recurrence at 8 months to 8 years following treatment.

Entities:  

Mesh:

Year:  1983        PMID: 6863076     DOI: 10.1016/0360-3016(83)90402-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

Review 1.  Radiation therapy and the management of intramedullary spinal cord tumors.

Authors:  S R Isaacson
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.

Authors:  Serap Akyurek; Eric L Chang; Tse-Kuan Yu; Darrin Little; Pamela K Allen; Ian McCutcheon; Anita Mahajan; Moshe H Maor; Shiao Y Woo
Journal:  J Neurooncol       Date:  2006-04-29       Impact factor: 4.130

Review 3.  Ependymomas in adults.

Authors:  Mark R Gilbert; Roberta Ruda; Riccardo Soffietti
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

4.  External beam radiotherapy for primary spinal cord tumors.

Authors:  H C Chun; R K Schmidt-Ullrich; A Wolfson; O F Tercilla; R H Sagerman; G A King
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

5.  Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults.

Authors:  Ung Kyu Chang; Woo Jin Choe; Sang Kee Chung; Chun Kee Chung; Hyun Jib Kim
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.

Authors:  Michael C Oh; Michael E Ivan; Matthew Z Sun; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Eli T Sayegh; Derick Aranda; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-12-09       Impact factor: 12.300

7.  Ependymoma of the filum terminale: treatment and prognostic factors in a series of 28 cases.

Authors:  P Celli; L Cervoni; G Cantore
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005).

Authors:  Dayron Rodríguez; Michael C Cheung; Nadine Housri; Alfredo Quinones-Hinojosa; Kevin Camphausen; Leonidas G Koniaris
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

Review 9.  Prognosis by tumor location in adults with intracranial ependymomas.

Authors:  Eli T Sayegh; Derick Aranda; Joseph M Kim; Taemin Oh; Andrew T Parsa; Michael C Oh
Journal:  J Clin Neurosci       Date:  2014-07-15       Impact factor: 1.961

Review 10.  Ependymomas.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.